# Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

> **NCT01407679** · PHASE2 · TERMINATED · sponsor: **University Hospital Muenster** · enrollment: 7 (actual)

## Conditions studied

- Lupus Erythematosus, Cutaneous

## Interventions

- **DRUG:** Alitretinoin

## Key facts

- **NCT ID:** NCT01407679
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2016-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407679, "Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01407679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*